SCOPUS 정보 검색 플랫폼

Progress in Neuro-Psychopharmacology and Biological Psychiatry

Volumn 25, Issue 1, 2001, Pages 73-89

Alzheimer's disease: Current and future therapeutic perspectives

(1) Gauthier, Serge a

a MCGILL UNIVERSITY (Canada)

Author keywords

Alzheimer's disease; Assessment of therapeutic response; Prevention; Symptomatic therapy

Indexed keywords

CHOLINE; CHOLINERGIC RECEPTOR STIMULATING AGENT; CHOLINESTERASE INHIBITOR; DONEPEZIL; GALANTAMINE; LINOPIRDINE; METRIFONATE; MILAMELINE; PHOSPHATIDYLCHOLINE; RIVASTIGMINE; SABCOMELINE; SABELUZOLE; TACRINE; TALSACLIDINE; XANOMELINE;

ALZHEIMER DISEASE; AUTOPSY; CARDIOTOXICITY; CHOLINERGIC SYSTEM; CLINICAL FEATURE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DAILY LIFE ACTIVITY; DEMENTIA; DOSE RESPONSE; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; FEMALE; GASTROINTESTINAL SYMPTOM; GENETIC ANALYSIS; HUMAN; LIVER TOXICITY; MALE; PATHOPHYSIOLOGY; POPULATION RESEARCH; RANDOMIZED CONTROLLED TRIAL; REVIEW; RISK FACTOR;

EID: 0035112954 PISSN: 02785846 EISSN: None Source Type: Journal
DOI: 10.1016/S0278-5846(00)00149-4 Document Type: Article

Times cited : (32)

References (90)

1
- 0005953299
- Anti-inflammatory therapy for Alzheimer's disease
- Alzheimer's Disease and Related Disorders Annual, S. Gauthier and J. Cummings (Eds.), Martin Dunitz, London
- (2000) , pp. 225-248
- Aisen, P.S.¹

2
- 0034620538
- A randomized controlled trial of prednisone in Alzheimer's disease
- (2000) Neurology , vol.54 , pp. 588-593
- Aisen, P.S.¹ Davis, K.L.² Berg, J.D.³ Schafer, K.⁴ Campbell, K.⁵ Thomas, R.G.⁶ Weiner, M.F.⁷ Farlow, M.R.⁸ Sano, M.⁹ Grundman, M.¹⁰ Thal, L.J.¹¹

3
- 0004235298
- Washington, DC
- (1994) th ed.)

4
- 4243311380
- The effects of rivastigmine on behavioral symptoms in severe AD patients in a nuring home setting
- (2000) Neurobiol Aging , vol.21 , Issue.SUPPL. 1
- Anand, R.¹ Koumaras, B.² Hartman, R.D.³

5
- 0032906515
- Functional impairment in instrumental activities of daily living: An early clinical sign of dementia?
- (1999) J.A.G.S. , vol.47 , pp. 456-462
- Barberger-Gateau, P.¹ Fabrigoule, C.² Helmer, C.³ Rouch, I.⁴ Dartigues, J.F.⁵

6
- 0021837319
- Survival in Alzheimer's disease and vascular dementia
- (1985) Neurology , vol.35 , pp. 834-840
- Barclay, L.L.¹ Zemcov, A.² Blass, J.P.³ Sansone, J.⁴

7
- 0023923356
- Mild Senile dementia of the Alzheimer type: 2. Longitudinal assessment
- (1988) Ann. Neurol. , vol.23 , pp. 477-484
- Berg, L.¹ Miller, J.P.² Storandt, M.³ Duchek, J.⁴ Morris, J.C.⁵ Rubin, E.H.⁶ Burke, W.J.⁷ Coben, L.A.⁸

8
- 0028099813
- Factors affecting course and survival in Alzheimer's disease
- (1994) Arch. Neurol. , vol.51 , pp. 1213-1219
- Bracco, L.¹ Gallato, R.² Grigolette, F.³ Lippi, A.⁴ Lepore, V.⁵ Bino, G.⁶ Lazzaro, M.P.⁷ Carella, F.⁸ Piccolo, T.⁹ Pozzilli, C.¹⁰ Giometto, B.¹¹ Amaducci, L.¹²

9
- 0032926540
- Donepezil in the treatment of Alzheimer's disease - Results from a multinational clinical trial
- (1999) Dement. Geriat. Cogn. Disord. , vol.10 , pp. 237-244
- Burns, A.¹ Rossor, M.² Hecker, J.³ Gauthier, S.⁴ Petit, H.⁵ Möller, H.J.⁶ Rogers, S.L.⁷ Friedhoff, L.T.⁸

10
- 0031902795
- A randomized trial evaluating the efficacy and safety of ENA 713 (rivastigmine tartrate), a new acetylcholinesterase inhibitor, in patients with mild to moderately severe Alzheimer's disease
- (1998) Int. J. Geriat. Psychopharmacol. , vol.1 , pp. 55-65
- Corey-Bloom, J.¹ Anand, R.² Veach, J.³

11
- 0001033736
- The efficacy of metrifonate in improving the behavioral disturbances of Alzheimer's disease
- (1998) Neurology , vol.50
- Cummings, J.L.¹ Cyrus, P.A.² Ruzicka, B.B.³ Gulanski, B.⁴

12
- 0031902295
- Alzheimer's disease. Etiologies, pathophysiology, cognitive reserve, and treatment opportunities
- (1998) Neurology , vol.51 , Issue.SUPPL. 1
- Cummings, J.L.¹ Vinters, H.V.² Cole, G.M.³ Khachaturian, Z.S.⁴

13
- 4244104344
- The dose-related improvement by metrifonate of the cognitive performance of Alzheimer's disease patients
- (1998) Neurology , vol.50
- Cyrus, P.A.¹ Ruzicka, B.B.² Gulanski, B.³

14
- 0034068646
- Predicting conversion to Alzheimer's disease using standardized clinical information
- (2000) Arch. Neurol. , vol.57 , pp. 675-680
- Daly, E.¹ Zaitchik, D.² Copeland, M.³ Scmahmann, J.⁴ Gunther, J.⁵ Albert, M.⁶

15
- 0024346285
- Measurement of quality-of-life changes in patients with Alzheimer's disease
- (1989) Clin. Ther. , vol.1 , pp. 545-554
- Dejong, R.¹ Osterlund, O.² Roy, G.³

16
- 0001691920
- Clinical benefits of donepezil: Results from a long-term phase III extension trial
- (1999) Neurology , vol.52 , Issue.SUPPL. 2
- Doody, R.S.¹ Pratt, R.D.²

17
- 0034076985
- Prospects for pharmacological intervention in Alzheimer's disease
- (2000) Arch. Neurol. , vol.57 , pp. 454-459
- Emilien, G.¹ Beyreuther, K.² Masters, C.L.³ Maloteaux, J.M.⁴

18
- 0031728926
- New treatments in Alzheimer Disease and the continued need for placebocontrolled trials
- (1998) Arch. Neurol. , vol.55 , pp. 1396-1398
- Farlow, M.R.¹

19
- 0031943549
- Treatment outcome of tacrine therapy depends on apolipoprotein genotype and gender of the subjects with Alzheimer's disease
- (1998) Neurology , vol.50 , pp. 669-677
- Farlow, M.R.¹ Lahiri, D.K.² Poirier, J.³ Davignon, J.⁴ Schneider, L.⁵ Hui, S.L.⁶

20
- 4243983607
- Metrifonate in the symptomatic treatment of Alzheimer's disease: Influence of apolipoprotein E genotype
- (1998) Neurology , vol.50
- Farlow, M.R.¹ Lahiri, D.K.² Brashear, A.³ Cyrus, P.A.⁴ Gulanski, B.⁵

21
- 0000290650
- Benefits of donepezil on global function, behavior, cognition and ADLs in patients with moderate to severe Alzheimer's disease
- (2000) Neurology , vol.54 , Issue.SUPPL. 3
- Feldman, H.¹ Gauthier, S.² Hecker, J.³ Vellas, B.⁴ Subbiah, P.⁵ Whalen, E.⁶

22
- 0016823810
- Mini Mental State: A practical method for grading the cognitive state of patients for the clinician
- (1975) J. Psychiat. Res. , vol.12 , pp. 189-198
- Folstein, M.F.¹ Folstein, S.E.² Mchugh, P.R.³

23
- 0032564132
- Prevention of dementia in randomized double-blind placebo-controlled Systolic Hypertension in Europe (Syst-Eur) trial
- (1998) Lancet , vol.352 , pp. 1347-1351
- Forette, F.¹ Seux, M.L.² Staessen, J.A.³ Thijs, L.⁴ Birkenhäger, W.H.⁵ Babarsjiene, M.R.⁶ Bossini, A.⁷ Gil-Extremera, B.⁸ Girerd, X.⁹ Laks, T.¹⁰ Lilov, E.¹¹ Moisseyev, V.¹² Tuomilehto, J.¹³ Vanhanen, H.¹⁴ Webster, J.¹⁵ Yodfat, Y.¹⁶ Fagard, R.¹⁷

24
- 0029050119
- The Consortium to establish a Registry for Alzheimer's Disease (CERAD). Part XI. Clinical milestones in patients with Alzheimer's disease followed over three years
- (1995) Neurology , vol.45 , pp. 1451-1455
- Galasko, D.¹ Edland, S.D.² Morris, J.C.³ Clark, C.⁴ Mohs, R.⁵ Koss, E.⁶

25
- 0031784155
- Clinical trials and therapy
- (1998) Current Opinion in Neurology , vol.11 , pp. 35-438
- Gauthier, S.¹

26
- 4244102248
- Cholinesterase inhibitors in the treatment of dementia
- Alzheimer's Disease and Related Disorders Annual, S. Gauthier and J. Cummings (Eds.), Martin Dunitz, London
- (2000) , pp. 199-210
- Gauthier, S.¹

27
- 0005914806
- Effects on decline or deterioration
- Alzheimer's Disease: From Molecular Biology to Therapy, R. Becker, E. Giacobini (Eds.), Birkhäuser, Boston
- (1996) , pp. 381-385
- Gauthier, S.¹ Poirier, J.² Gray, J.³

28
- 0002272148
- The efficacy of metrifonate in enhancing the ability of Alzheimer's disease patients to perform basic and instrumental activities of daily living
- (1998) Neurology , vol.50
- Gelinas, I.¹ Gauthier, S.² Cyrus, P.A.³ Ruzicka, B.B.⁴ Gulanski, B.⁵

29
- 0033193134
- Development of a functional measure for persons with Alzheimer's disease: The Disability Assessment of Dementia
- (1999) A.J.O.T. , vol.53 , pp. 471-481
- Gelinas, I.¹ Gauthier, L.² Mcintyre, M.³ Gauthier, S.⁴

30
- 0031904324
- Abnormalities of neural circuitry in Alzheimer's disease
- (1998) Neurology , vol.51 , Issue.SUPPL. 1
- Geula, C.¹

31
- 0001885399
- Cholinesterase inhibitors: From the Calabar bean to Alzheimer therapy
- Cholinesterases and cholinesterase inhibitors, E. Giacobini (Ed.), Martin Dunitz, London
- (2000) , pp. 181-226
- Giacobini, E.¹

32
- 0034711656
- Estrogen for Alzheimer's disease in women
- (2000) Neurology , vol.54 , pp. 295-301
- Henderson, V.W.¹ Paganini-Hill, A.² Miller, B.L.³ Elble, R.J.⁴ Reyes, P.F.⁵ Shoupe, D.⁶ McClary, C.A.⁷ Klein, R.A.⁸ Hake, A.M.⁹ Farlow, M.R.¹⁰

33
- 0030000603
- The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part XIV: Demographic and clinical predictors of survival in patients with Alzheimer's disease
- (1996) Neurology , vol.46 , pp. 656-660
- Heyman, A.¹ Peterson, B.² Fillenbaum, G.³ Pieper, C.⁴

34
- 0030898181
- Predictors of time to institutionalization of patients with Alzheimer's disease. The CERAD experience, part XVII
- (1997) Neurology , vol.48 , pp. 1304-1309
- Heyman, A.¹ Peterson, B.² Fillenbaum, G.³ Pieper, C.⁴

35
- 0033996985
- Predicting who will develop dementia in a cohort of canadian seniors
- (2000) Can. J. Neurol. Sci. , vol.27 , pp. 18-24
- Hogan, D.B.¹ Ebly, E.B.²

36
- 14444269228
- Longitudinal study of cerebrospinal fluid levels of tau, Abeta1-40, and Abeta1-42(43) in Alzheimer's disease: A study in Japan
- (1998) Ann Neurol. , vol.44 , pp. 17-26
- Kanai, M.¹ Matsubara, E.² Isoe, K.³ Urakami, K.⁴ Nakashima, K.⁵ Arai, H.⁶ Sasaki, H.⁷ Abe, K.⁸ Iwarsubo, T.⁹ Kosaka, T.¹⁰ Watanabe, M.¹¹ Tomidokoro, Y.¹² Shizuka, M.¹³ Mizushima, K.¹⁴ Nakamura, T.¹⁵ Igeta, Y.¹⁶ Ikeda, Y.¹⁷ Amari, M.¹⁸ Kawarabayashi, T.¹⁹ Ishiguro, K.²⁰ more..

37
- 0031759238
- Is the placebo control obsolete in a world after donepezil and vitamin E?
- (1998) Arch. Neurol. , vol.55 , pp. 1420-1424
- Karlawish, J.H.T.¹ Whitehouse, P.²

38
- 0023777591
- Comparison of annual change of mental status score in four independent studies of patients with Alzheimer's disease
- (1988) Ann. Neurol. , vol.24 , pp. 384-389
- Katzman, R.¹ Brown, T.² Thal, L.J.³ Fuld, P.A.⁴ Aronson, M.⁵ Butters, N.⁶ Klauber, M.R.⁷ Wiederholt, W.⁸ Pay, M.⁹ Renbing, X.¹⁰ Lock Ooi, W.¹¹ Hofstetter, R.¹² Terry, R.¹³

39
- 0029914548
- Effects of tacrine on behavioral symptoms in Alzheimer's disease: An open label study
- (1996) J. Geriatr. Psychiatry Neurol. , vol.9 , pp. 1-6
- Kaufer, D.I.¹ Cummings, J.L.² Christine, D.³

40
- 0026825733
- The five-five, ten-ten plan for Alzheimer's disease
- (1992) Neurobiol. Aging , vol.13 , pp. 197-198
- Khachaturian, Z.¹

41
- 0030035653
- Long-term tacrine (Cognex) treatment: Effects on nursing home placement and mortality
- (1996) Neurology , vol.47 , pp. 166-177
- Knopman, D.¹ Schneider, L.² Davis, K.³ Talwalker, S.⁴ Smith, F.⁵ Hoover, T.⁶ Gracon, S.⁷

42
- 0031759502
- Clinical research designs for emerging treatments to Alzheimer's diseaase: Moving beyond placebo-controlled trials
- (1998) Arch. Neurol. , vol.55 , pp. 1425-1429
- Knopman, D.¹ Kahn, J.² Miles, S.³

43
- 0030865454
- Slowing the progression of Alzheimer's disease: Methodological issues
- (1997) Alz. Dis. Assoc. Disord. , vol.11 , Issue.SUPPL. 5
- Leber, P.¹

44
- 0027393529
- Rate of progression and prognostic factors in Alzheimer's disease: A prospective study
- (1993) J.A.G.S. , vol.41 , pp. 45-49
- Lucca, U.¹ Comelli, M.² Tettamanti, M.³ Tiraboshi, P.⁴ Spagnoli, A.⁵

45
- 0034643827
- Estrogen to treat Alzheimer's disease: Too little, too late?
- (2000) Neurology , vol.54 , pp. 2035-2037
- Marder, K.¹ Sano, M.²

46
- 0000057203
- Clinical diagnosis of Alzheimer's disease: Report of the NINCDS-ADRDA workgroup
- (1984) Neurology , vol.34 , pp. 939-944
- McKahnn, G.¹ Drachman, D.² Folstein, M.³ Katzman, R.⁴ Price, D.⁵ Stadlan, E.M.⁶

47
- 0030445619
- A family intervention to delay nursing home placement of patients with Alzheimer's disease
- (1996) J.A.M.A. , vol.276 , pp. 1725-1731
- Mittelman, M.S.¹ Ferris, S.H.² Shulman, E.³ Steinberg, G.⁴ Levin, B.⁵

48
- 0004026751
- Presented at the College of European Neuropsychopharmacology, London, Sept 1999
- (1999) Donepezil preserves functional status in Alzheimer's disease patients: results from a 1-year prospective placebo-controlled study
- Mohs, R.¹ Doody, R.² Morris, J.³ Ieni, J.R.⁴ Rogers, S.⁵ Perdomo, C.A.⁶ Pratt, R.D.⁷

49
- 0027749448
- The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part IV. Rates of cognitive change in the longitudinal assessment of probable Alzheimer's disease
- (1993) Neurology , vol.43 , pp. 2457-2465
- Morris, J.C.¹ Edland, S.² Clark, C.³ Galasko, D.⁴ Koss, E.⁵ Mohs, R.⁶ Van Belle, G.⁷ Fillenbaum, G.⁸ Heyman, A.⁹

50
- 0027425211
- The Clinical Dementia Rating (CDR): Current version and scoring rules
- (1993) Neurology , vol.43 , pp. 2412-2413
- Morris, J.C.¹

51
- 0031842293
- Metrifonate benefits cognitive, behavioral and global function in patients with Alzheimer's disease
- (1998) Neurology , vol.50 , pp. 1222-1230
- Morris, J.C.¹ Cyrus, P.A.² Orazem, J.³ Mas, J.⁴ Bieber, F.⁵ Ruzicka, B.B.⁶ Gulanski, B.⁷

52
- 0026784959
- Predictors of cognitive and functional progression in patients with probable Alzheimer's disease
- (1992) Neurology , vol.42 , pp. 1689-1696
- Mortimer, J.A.¹ Ebbitt, B.² Sung-Pyo, J.³ Finch, M.D.⁴

53
- 0028152357
- Severe Impairment Battery. A neuropsychological test for severely demented patients
- (1994) Arch. Neurol. , vol.51 , pp. 41-45
- Panisset, M.¹ Roudier, M.² Saxton, J.³ Boller, F.⁴

54
- 0032988610
- Mild cognitive impairment. Clinical characterization and outcome
- (1999) Arch. Neurol. , vol.56 , pp. 303-308
- Petersen, R.C.¹ Smith, G.E.² Waring, S.C.³ Ivnik, R.J.⁴ Tangalos, E.G.⁵ Kohmen, E.⁶

55
- 0007691164
- Apolipoprotein E4 allele as a predictor of cholinergic deficits and treatment outcome in Alzheimer disease
- (1995) Proc. Natl. Acad. Sci. USA , vol.92 , pp. 12260-12264
- Poirier, J.¹ Delisle, M.C.² Quirion, R.³ Aubert, I.⁴ Farlow, M.⁵ Lahiri, D.⁶ Hui, S.⁷ Bertrand, P.⁸ Nalbantoglu, J.⁹ Gilfix, B.M.¹⁰ Gauthier, S.¹¹

56
- 85058251199
- ApoE as a therapeutic target for the treatment of Alzheimer's disease
- (2000) Neurobiol. Aging , vol.21 , Issue.SUPPL. 1S
- Poirier, J.¹ Panisset, M.²

57
- 0005914698
- Clinical development of galantamine: Evaluation of a compound with possible acetylcholinesterase inhibiting and nicotinic modulatory activity
- (1998) Neurobiol. Aging , vol.19 , pp. 57
- Pontecorvo, M.J.¹

58
- 4243983852
- Societal and ethical considerations
- Pharmacotherapy of Alzheimer's disease. S. Gauthier (Ed), Martin Dunitz, London
- (1998) , pp. 113-122
- Post, S.G.¹

59
- 0032567128
- Cholinesterase inhibition for Alzheimer disease. A meta-analysis of the tacrine trials
- (1998) J.A.M.A. , vol.280 , pp. 1777-1782
- Qizilbash, N.¹ Whitehead, A.² Higgins, J.³ Wilcock, G.⁴ Schneider, L.⁵ Farlow, M.⁶

60
- 0030851210
- Effects of tacrine on language, praxis and concognitive behavioral problems in Alzheimer's disease
- (1997) Arch. Neurol. , vol.54 , pp. 836-840
- Raskind, M.A.¹ Sadowsk, C.H.² Sigmund, W.R.³ Beitler, P.J.⁴ Auster, S.B.⁵

61
- 0034720816
- Galantamine in AD. A 6-month randomized, placebo-controlled trial with a 6-month extension
- (2000) Neurology , vol.54 , pp. 2261-2268
- Raskind, M.A.¹ Peskind, E.R.² Wessel, T.³ Yuan, W.⁴

62
- 0031883716
- A 24-week, double-blind, placebo-controlled trial of donepezil in patients with Alzheimer's disease
- (1998) Neurology , vol.50 , pp. 136-145
- Rogers, S.L.¹ Farlow, M.R.² Doody, R.S.³ Mohs, R.⁴ Friedhoff, L.T.⁵

63
- 0031983322
- Long-term efficacy and safety of donepezil in the treatment of Alzheimer's disease: An interim analysis of the results of a US multicentre open label extension study
- (1998) Europ. Neuropsychopharmacol. , vol.8 , pp. 67-75
- Rogers, S.L.¹ Friedhoff, L.T.²

64
- 85058251409
- Unbiased detection of atrophy in mild to moderate Alzheimer's disease
- (2000) Neurobiol. Aging , vol.21 , Issue.SUPPL. 1
- Rombouts, S.¹ Barkof, F.² Witter, M.P.³ Scheltens, P.⁴

65
- 0021520020
- A new rating scale for Alzheimer's disease
- (1984) Am. J. Psychiatry , vol.141 , pp. 1356-1364
- Rosen, W.G.¹ Mohs, R.C.² Davis, K.L.³

66
- 0034643888
- The molecular and genetic basis of AD: The end of the beginning
- (2000) Neurology , vol.54 , pp. 2045-2054
- Rosenberg, R.N.¹

67
- 0033528436
- Efficacy and safety of rivastigmine in patients with Alzheimer's disease: Results of an international, 26-week, multicentre, randomised, placebo-controlled trial
- (1999) Brit. Med. J. , vol.318 , pp. 633-638
- Rösler, M.¹ Anand, R.² Cicin-Sain, A.³ Gauthier, S.⁴ Agid, Y.⁵ Dal-Bianco, P.⁶ Statelin, H.B.⁷ Hartman, R.⁸ Gharabawi, M.⁹

68
- 0003012239
- Results of a double-blind, randomized, placebo-controlled study of celecoxib in the treatment of progression of Alzheimer's disease
- Stockholm, April 5-8, 2000
- (2000) th International Stockholm/Springfield Symposium on Advances in Alzheimer Therapy
- Sainati, S.M.¹ Ingram, D.M.² Talwalker, S.³ Geis, G.S.⁴

69
- 0032890866
- Assessing individual patients for cognitive benefits from acetylcholinesterase inhibitors
- (1999) Alzheimer Dis. Assoc. Dis. , vol.13 , pp. 26-33
- Sands, L.P.¹ Katz, I.² Schneider, L.³

70
- 0030967165
- A controlled trial of selegiline, alpha-tocopherol, or both as treatment for Alzheimer's disease
- (1997) N. Engl. J. Med. , vol.326 , pp. 1245-1247
- Sano, M.¹ Ernesto, C.² Thomas, R.G.³ Klauber, M.R.⁴ Schafer, K.⁵ Grundman, M.⁶ Woodbury, P.⁷ Growdon, J.⁸ Cotman, C.W.⁹ Pfeiffer, E.¹⁰ Schneider, L.S.¹¹ Thal, L.J.¹²

71
- 0033536163
- Immunization with amyloid- beta attenuates Alzheimer-disease-like pathology in the PDAPP mouse
- (1999) Nature , vol.400 , pp. 173-177
- Schenk, D.B.¹ Barbour, R.² Dunn, W.³ Gordon, G.⁴ Grajeda, H.⁵ Guido, T.⁶ Hu, K.⁷ Huang, J.⁸ Johnson-Wood, K.⁹ Khan, K.¹⁰ Kholodenko, D.¹¹ Lee, M.¹² Liao, Z.¹³ Lieberburg, I.¹⁴ Motter, R.¹⁵ Mutter, L.¹⁶ Soriano, F.¹⁷ Shopp, G.¹⁸ Vasquez, N.¹⁹ Vandevert, C.²⁰ more..

72
- 0031844755
- The pharmacological basis for metrifonate's favourable tolerability in the treatment of Alzheimer's disease
- (1998) Dement. Geriatr. Cogn. Disord. , vol.9 , Issue.SUPPL. 2 , pp. 15-19
- Schmidt, B.H.¹ Heinig, R.²

73
- 0031647045
- Systematic review of the efficacy of rivastigmine for patients with Alzheimer's disease
- (1998) Int. J. Geriat. Psychopharmacol. , vol.1 , Issue.SUPPL. 1
- Schneider, L.S.¹ Anand, R.² Farlow, M.R.³

74
- 0026463333
- Functional Assessent Staging (FAST) in Alzheimer's disease: Reliability, validity, and ordinality
- (1992) Int. Psychogeriatr. , vol.4 , Issue.SUPPL. 1 , pp. 55-69
- Sclan, S.G.¹ Reisberg, B.²

75
- 0029740341
- The behavior pathology in Alzheimer's disease rating scale (Behave-AD): Reliability and analysis of symptom category scores
- (1996) Institutional J. Ger. Psychiat. , vol.11 , pp. 1-11
- Sclan, S.G.¹ Saillon, A.² Franssen, E.³ Hugonot-Diener, L.⁴ Saillon, A.⁵

76
- 0034079660
- Mild Cognitive Impairment: Potential pharmacological treatment options
- (2000) J.A.G.S. , vol.48 , pp. 431-441
- Sherwin, B.B.¹

77
- 0031054674
- Brain infarction and the clinical expression of Alzheimer disease. The Nun Study
- (1997) J.A.M.A. , vol.277 , pp. 813-817
- Snowdon, D.A.¹ Greiner, L.H.² Mortimer, J.A.³ Riley, K.P.⁴ Greiner, P.A.⁵ Markesbery, W.R.⁶

78
- 8044242205
- Predicting time to nursing home care and death in individuals with Alzheimer's disease
- (1997) J.A.M.A. , vol.277 , pp. 806-812
- Stern, Y.¹ Min-Xing, T.² Albert, M.S.³ Brandt, J.⁴ Jacobs, D.M.⁵ Bell, K.⁶ Marder, K.⁷ Sano, M.⁸ Devenand, D.⁹ Albert, S.M.¹⁰ Bylsma, F.¹¹ Tsai, W.Y.¹²

79
- 0034720864
- A 5-month, randomized, placebo-controlled trial of galantamine in AD
- (2000) Neurology , vol.54 , pp. 2269-2276
- Tariot, P.N.¹ Solomon, P.R.² Morris, J.C.³ Kershaw, P.⁴ Lilienfeld, S.⁵ Ding, C.⁶

80
- 0030634117
- Prevention protocols for Alzheimer's disease
- (1997) Alzheimer Dis. Assoc. Disord. , vol.11 , Issue.SUPPL. 3 , pp. 46-49
- Thal, L.J.¹ Carta, A.² Doody, R.³ Leber, P.⁴ Mohs, R.⁵ Schneider, L.⁶ Shimohama, S.⁷ Silber, C.⁸

81
- 0030626839
- Protocols to demonstrate slowing of Alzheimer's disease progression
- Position paper from the International working Group on Harmonization of Dementia Drug Guidelines
- (1997) Alzheimer Dis. Assoc. Disord. , vol.11 , Issue.SUPPL. 3 , pp. 50-53

82
- 0032237793
- Clinical trial designs for demonstrating disease- course-altering effects in dementia
- (1998) Alzheimer Dis. Assoc. Disord. , vol.12 , pp. 281-294
- Whitehouse, P.J.¹ Kittner, B.² Roessner, M.³ Rossor, M.⁴ Sano, M.⁵ Thal, L.⁶ Winblad, B.⁷

83
- 0000325982
- Neotrofin: Novel approach for Alzheimer's disease
- (2000) Neurobiol. Aging , vol.21 , Issue.SUPPL. 1S
- Wieland, S.¹ Molloy, W.² Targum, S.³ Mohr, E.⁴ Glasky, M.⁵ Glasky⁶

84
- 0001764191
- Donepezil enhances global function, cognition and activities of daily living compared with placebo in a one year, doubleblind trial in patients with mild to moderate Alzheimer's disease
- (1999) Int. Psychogeriatrics , vol.11 , Issue.SUPPL. 1 , pp. 138
- Winblad, B.¹ Engedal, K.² Soininen, H.³ Verhey, F.⁴ Waldemar, G.⁵ Wimo, A.⁶ Wetterholm, A.L.⁷ Zhang, R.⁸ Haglund, A.⁹ Subbiah, P.¹⁰

85
- 0032983786
- Memantine in severe dementia: Results of the 9M-BEST Study (Benefits and Efficacy in Severeley demented patients during treatment with memantine)
- (1999) Int. J. Geriat. Psychiatry , vol.14 , pp. 135-146
- Winblad, B.¹ Porotis, N.²

86
- 0032749772
- Severe dementia: A common condition entailing high costs at individual and societal levels
- (1999) Int. J. Geriat. Psychiatry , vol.14 , pp. 911-914
- Winblad, B.¹ Wimo, A.² Möbius, H.J.³ Fox, J.M.⁴ Fratiglioni, L.⁵

87
- 0034123691
- Mechanisms of neurodegenerative disorders. Part 1: Protein aggregates
- (2000) Arch. Neurol. , vol.57 , pp. 793-796
- Wolozin, B.¹ Behl, C.²

88
- 0034051284
- Mechanisms of neurodegenerative disorders. Part 2: Control of cell death
- (2000) Arch. Neurol. , vol.57 , pp. 801-804
- Wolozin, B.¹ Behl, C.²

89
- 0034491582
- Is placebo control in geriatric psychopharmacology clinical trials ethical?
- in press
- (2000) Int. J. Geriat. Psychopharmacol.
- Young, S.N.¹ Gauthier, S.²

90
- 0022727344
- Subjective burden of husbands and wives as caregivers: A longitudinal study
- (1986) The Gerontologist , vol.26 , pp. 260-266
- Zarit, S.H.¹ Todd, P.A.² Zarit, J.M.³

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.